Smart Insulin Pens Market 2020: Comprehensive Study Explores Huge Growth in Future Top Key Players Companion Medical, Inc., BIOCORP, Novo Nordisk, Sanofi Diabetes, Medtronic, plc., BD, Animas, Roche, Insulet, Bomtech, BioSampling, Cardiocomm Solutions

In this report, the "United States Smart Insulin Pens Market" is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025.

Smart insulin pens are connected insulin pens that are reusable and work with insulin cartridges. Some of the advantages of smart insulin pens include, automatic record of injected amount of insulin, no need of logs, reduced cases of accidental insulin stacking, and access to computer-generated reports.

Increasing prevalence of diabetes is a major factor boosting growth of the U.S. smart insulin pens market over the forecast period. For instance, according to International Diabetes Federation’s IDF Diabetes Atlas 2019 Edition, the numbers of adults with diabetes in the U.S. was 31.0 million. Moreover, increasing initiatives of government and private organizations for the treatment for diabetes in low- and middle-income countries is also expected to offer lucrative growth opportunities for players in the U.S. smart insulin pens market. For instance, in November 2019, The World Health Organization (WHO) announced the start of a pilot program to prequalify human insulin to increase treatment for diabetes in low- and middle-income countries.

Download In-Depth Sample Copy of Research @ https://www.stratagemmarketinsights.com/sample/8862
(*** Note: Sample Copy FREE with TOC, Graphs, and Charts)

Increasing geriatric population susceptible to diabetes is expected to aid in growth of the market. For instance, according to the U.S. Census Bureau, geriatric population in the U.S. is expected to reach 77 million by 2035. Moreover, increasing demand for self-injection devices and accuracy in dosage delivery of insulin is also contributing to growth of the market.

However, restricted usage of smart insulin pens in patients that require a combination of two types of insulin is expected to hamper growth of the U.S. smart insulin pens market.

Key players in the market are focused on adopting collaboration and partnership strategies to expand their product portfolio. For instance, in June 2019, Companion Medical, Inc. collaborated with DexCom, Inc. to enable a direct exchange of CGM data from Dexcom with insulin data from InPen into both companies’ software applications. Similarly, in December 2019, BIOCORP, a medical devices and smart drug delivery systems developer based in France, partnered with SANOFI for the use of Mallya technology, a connected device for insulin pens.

Key Takeaways:

• Increasing prevalence of diabetes is expected to augment growth of the U.S. smart insulin pens market

• Restricted usage of smart insulin pens in patients that require a combination of two types of insulin is expected to hamper growth of the market

• Major players operating in the U.S. smart insulin pens market include, Companion Medical, Inc., BIOCORP, Novo Nordisk, Sanofi Diabetes, Medtronic, plc., BD, Animas, Roche, Insulet, Bomtech, BioSampling, Cardiocomm Solutions, Henke-Sass, Kavo, Megasan Medical, Nipro, Mika Medical, Rudolf Riester, and Smiths Medical

Geographically, this report splits the United States market into seven regions:
- The West
- Southwest
- The Middle Atlantic
- New England
- The South
- The Midwest
with sales (volume), revenue (value), market share and growth rate of Smart Insulin Pens in these regions, from 2014 to 2025 (forecast).

Click Here for any Query, Our Expert will Assist you: https://www.stratagemmarketinsights.com/quiry/8862

United States Smart Insulin Pens market competition by top manufacturers/players, with Smart Insulin Pens sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
* Novo Nordisk
* Sanofi Diabetes
* Medtronic
* BD
* Animas
* Roche
* Insulet
* Bomtech
* BioSampling
* Cardiocomm Solutions
* Henke-Sass
* Kavo
* Megasan Medical
* Nipro
* Mika Medical
* Rudolf Riester
* Smiths Medical

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
- Bluetooth Connected Smart Insulin Pens
- USB Connected Smart Insulin Pens

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Smart Insulin Pens for each application, including
- Clinics and Ambulatory Surgical Centres
- e-Commerce
- Retail Pharmacies

[*** If you have any special requirements, please let us know and we will offer you the report as you want.]

Buy Smart Insulin Pens Market Research Study Report @ https://www.stratagemmarketinsights.com/cart/8862

Get In Touch:

Mr. Shah
Stratagem Market Insights
Tel: +1-415-871-0703
Email: sales@stratagemmarketinsights.com
Visit Here: https://healthcareinsights786.blogspot.com/

About Us:

Stratagem Market Insights is a management consulting organization providing market intelligence and consulting services worldwide. We bring the expertise of consultants with an cumulative industry experience of more than 70 years. The firm has been providing quantified B2B research and currently offers services to over 350+ customers worldwide. Our reports cover various end-use industries such as Aerospace and Defense, Agriculture, Food and Beverages, Automotive, Chemicals and Materials, Consumer Goods and Retail, Electronics, Energy, Mining, and Utilities, Pharmaceuticals, Manufacturing and Construction, Services, and Healthcare, and ICT.

This release was published on openPR.